Please login to the form below

Not currently logged in
Email:
Password:

Lupin names chief corporate development officer

Theresa Stevens has experience at Novartis and Aptalis

Lupin Theresa StevensLupin has appointed Theresa Stevens as chief corporate development officer for its global operations.

Stevens joins the India-based pharma company from Aptalis Pharma, where she was chief corporate development officer for mergers and acquisitions, strategy and global business development.

Prior to this Steven spent nine years at Novartis, serving in such roles as head of global business development and licensing.

She holds degrees in both biochemisty and law, and has previously worked as a research scientist at Dupont and as a lawyer at Pennie & Edmonds.

Lupin's decision to hire Stevens follows its appointment earlier this year of Teva's Dr Maurice Chagnaud as president, Europe, and head of inhalation strategy.

According to the company, these hires are part of a push to expand the company beyond its home market by improving its performance in the US, Europe and key emerging markets.

25th April 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics